HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

3- (4- amino- 3- methylbenzyl)- 7- (2- furyl)- 3H- (1,2,3)triazolo(4,5- d)pyrimidine- 5- amine

Subscribe to New Research on 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine

antiparkinson agent; structure in first source

Also Known As:

BIIB014; V 2006; V-2006; V2006 cpd

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 60
- 1-Ring Heterocyclic Compounds
  - Azoles: 413
    - Triazoles: 187
      - 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine: 2
  - Pyrimidines: 319
    - 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine: 2

Experts

1.	Tuttle, Todd M: 1 article (07/2010)
2.	Abbott, Andrea: 1 article (07/2010)
3.	Habermann, Elizabeth B: 1 article (07/2010)
4.	Al-Refaie, Waddah B: 1 article (07/2010)
5.	Virnig, Beth A: 1 article (07/2010)
6.	Parsons, Helen M: 1 article (07/2010)
7.	Tong, Xin: 1 article (01/2009)
8.	Bamford, Samantha J: 1 article (01/2009)
9.	Comer, Mike: 1 article (01/2009)
10.	Padfield, Antony: 1 article (01/2009)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 01/08/2009 - "These efforts have led to the discovery of 60 (V2006/BIIB014), which demonstrates strong oral activity in commonly used models of Parkinson's disease. "
2.	Neoplasms (Cancer) 07/20/2010 - "Women were less likely to receive mastectomy over time (odds ratio, 1.18 for 2000 v 2006; 95% CI, 1.14 to 1.23; P < .0001), after adjusting for patient and tumor factors. "

Related Therapies and Procedures

1.	Mastectomy (Mammectomy)